CAMBRIDGE, Mass. & ANKARA, Turkey--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and Gen Ilac, a leading Turkish pharmaceutical company focused on the supply of orphan drugs for the treatments of rare diseases, today announced that ARIAD has granted Gen Ilac exclusive rights to distribute Iclusig® (ponatinib) in Turkey for patients with Philadelphia-positive leukemias.
Help employers find you! Check out all the jobs and post your resume.
